Current Report Filing (8-k)
July 19 2016 - 8:51AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 14, 2016
AGENUS INC.
(Exact name
of registrant as specified in its charter)
|
|
|
|
|
DELAWARE
|
|
000-29089
|
|
06-1562417
|
(State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer
|
of incorporation)
|
|
File Number)
|
|
Identification No.)
|
|
|
3 Forbes Road
Lexington, MA
|
|
02421
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: 781-674-4400
N/A
(Former name or
former address, if changed since last report.)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
On July 14, 2016, C. Evan Ballantyne, Chief Financial Officer of Agenus Inc.
(Agenus), informed Agenus of his intention to resign effective as of July 29, 2016. Christine M. Klaskin, Agenus Vice President, Finance and principal accounting officer, will retain her roles and assume the role of principal
financial officer. Ms. Klaskin has served in various finance roles at Agenus since 1996. Additional biographical information about Ms. Klaskin is contained in Agenus prior filings with the Securities and Exchange Commission.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
|
|
|
|
Date: July 19, 2016
|
|
|
|
AGENUS INC.
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Garo H. Armen, Ph.D.
|
|
|
|
|
|
|
Garo H. Armen, Ph.D.
|
|
|
|
|
|
|
Chief Executive Officer and
|
|
|
|
|
|
|
Chairman of the Board
|
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Sep 2023 to Sep 2024